Comments Posted on the Docket So Far Regarding the FDA Guidance on Pharmacy Compounding of Human Drug Products Under Section 503A (2 posted; 5 comments received so far)

Comment from Michael Rogers

• Although I understand that compounding pharmacies cannot compound replicas of drugs on the market I think a exception should be made if there is a true need where the patient...

• Public Submission
• Posted:
  01/13/2014
• ID:
  FDA-2013-D-1444-0003

• Agency:
  FDA
• RIN:
  Not Assigned
• Docket ID:
  FDA-2013-D-1444

• Organization:
• Submitter Name:

Comment Now!

Comments Due
Feb 03, 2014 11:59 PM ET

Comment from National Home Infusion Association (NHIA)

• NHIA Comments to Margaret A. Hamburg, M.D. Re: Draft Guidance “Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act” Docket...

• Public Submission
• Posted:
  01/13/2014
• ID:
  FDA-2013-D-1444-0004